Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionSentinel Trust Co Lba
Latest Disclosed Ownership46,238 shares
Latest Disclosed Value $ 1,699
Sentinel Trust Co Lba ownership in NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 7, 2026 - Sentinel Trust Co Lba filed a 13F-HR form disclosing ownership of 46,238 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $1,458,809 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 46,238 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,656,245 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ADR Novo-Nordisk ADR 670100205 46,238 0 0.00 2 -50.00 0.1688
2026-01-29 2025-12-31 13F ADR Novo-Nordisk ADR 670100205 46,238 0 0.00 2 0.00 0.2317
2025-11-04 2025-09-30 13F ADR Novo-Nordisk ADR 670100205 46,238 2,066 4.68 3 -33.33 0.2615
2025-07-31 2025-06-30 13F ADR Novo-Nordisk ADR 670100205 44,172 0 0.00 3 0.00 0.3311
2025-05-01 2025-03-31 13F ADR Novo-Nordisk ADR 670100205 44,172 -194 -0.44 3 0.00 0.3618
2025-02-05 2024-12-31 13F ADR Novo-Nordisk ADR 670100205 44,366 194 0.44 4 -40.00 0.4381
2024-10-15 2024-09-30 13F ADR Novo-Nordisk ADR 670100205 44,172 0 0.00 5 -16.67 0.5989
2024-08-13 2024-06-30 13F ADR Novo-Nordisk ADR 670100205 44,172 0 0.00 6 20.00 0.7750
2024-05-15 2024-03-31 13F ADR Novo-Nordisk ADR 670100205 44,172 0 0.00 6 25.00 0.7328
2024-02-13 2023-12-31 13F ADR Novo-Nordisk ADR 670100205 44,172 0 0.00 5 0.00 0.6003
2023-11-14 2023-09-30 13F ADR Novo-Nordisk ADR 670100205 44,172 22,922 107.87 4 33.33 0.5693
2023-08-03 2023-06-30 13F ADR Novo-Nordisk ADR 670100205 21,250 0 0.00 3 0.00 0.4677
2023-05-05 2023-03-31 13F ADR Novo-Nordisk ADR 670100205 21,250 21,250 3 0.4806
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.